What is the address of Dr. Marleen Vandepitte, huisarts?

The registered office of Dr. Marleen Vandepitte, huisarts is located at Sint-Lievenspoortstraat 257 box 1, 9000 Gent.

Is Dr. Marleen Vandepitte, huisarts still active?

Yes. According to the CBE (2 November 2026) Dr. Marleen Vandepitte, huisarts is active, legal situation “Normale toestand”, started on 6 December 2010.

Is Dr. Marleen Vandepitte, huisarts registered on Peppol?

Yes, Dr. Marleen Vandepitte, huisarts is registered on the Peppol network with ID 0208:0831631181.

What is the enterprise number of Dr. Marleen Vandepitte, huisarts?

The enterprise number of Dr. Marleen Vandepitte, huisarts is BE0831631181.

When was Dr. Marleen Vandepitte, huisarts founded?

Dr. Marleen Vandepitte, huisarts was founded on 6 December 2010.

Who are the directors of Dr. Marleen Vandepitte, huisarts?

According to the 2025 annual accounts, the directors of Dr. Marleen Vandepitte, huisarts are: Marleen Vandepitte.

Is Dr. Marleen Vandepitte, huisarts a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 6 December 2010; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account; 1 events from the Belgian Official Gazette processed.

How much profit did Dr. Marleen Vandepitte, huisarts make in 2025?

Dr. Marleen Vandepitte, huisarts posted a profit after taxes of € 36,197 in financial year 2025.

What is the revenue of Dr. Marleen Vandepitte, huisarts?

As a small company, Dr. Marleen Vandepitte, huisarts is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 60,010.

Dr. Marleen Vandepitte, huisarts (Private Limited) - Gent

Dossier Dr. Marleen Vandepitte, huisarts, printed on 3 November 2026 from databakkes.be/en/0831631181/dr-marleen-vandepitte-huisarts. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

Dr. Marleen Vandepitte, huisarts from Gent, company number BE0831631181, closed financial year 2025 with a result of € 36,197 after tax. For that financial year Dr. Marleen Vandepitte, huisarts recorded a gross margin of € 60,010 and equity of € 133,874. Compared with financial year 2024, the result moved from € 32,109 to € 36,197. Profitable, and profit is growing. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 20, 2026.

What it is worth Healthy

€ 133,874

▼ 11% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 36,197

▲ 13% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 12,740

▼ 83% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 53,050 paid out

More than the year’s profit went to the shareholders; reserves fell.

People and assets in 2025

Full-time equivalents estimate The annual accounts report no full-time equivalents. A micro company with one active director is usually run by that person; this is an assumption, not a figure from the source.

≈ 1

No payroll staff. One director, so that person most likely runs the business.

Vehicles and equipment

€ 2,644

▼ 33% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt

€ 3,157

▼ 80% vs 2024

Loans from banks and other lenders, long and short.

Owed to suppliers

€ 657

▼ 81% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 4,822

▼ 77% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 48,709 Gross margin 2022: € 48,709 First fiscal year in the series	€ 62,823 Gross margin 2023: € 62,823 ▲ 29% vs 2022 (€ 48,709) Favourable step	€ 54,631 Gross margin 2024: € 54,631 ▼ 13% vs 2023 (€ 62,823) Unfavourable step	€ 60,010 Gross margin 2025: € 60,010 ▲ 10% vs 2024 (€ 54,631) Favourable step	▲ 10%
Profit after taxes	€ 27,294 Profit after taxes 2022: € 27,294 First fiscal year in the series	€ 37,275 Profit after taxes 2023: € 37,275 ▲ 37% vs 2022 (€ 27,294) Favourable step	€ 32,109 Profit after taxes 2024: € 32,109 ▼ 14% vs 2023 (€ 37,275) Unfavourable step	€ 36,197 Profit after taxes 2025: € 36,197 ▲ 13% vs 2024 (€ 32,109) Favourable step	▲ 13%
Equity	€ 109,877 Equity 2022: € 109,877 First fiscal year in the series	€ 142,267 Equity 2023: € 142,267 ▲ 29% vs 2022 (€ 109,877) Favourable step	€ 150,728 Equity 2024: € 150,728 ▲ 6% vs 2023 (€ 142,267) Favourable step	€ 133,874 Equity 2025: € 133,874 ▼ 11% vs 2024 (€ 150,728) Unfavourable step	▼ 11%
Total debts	€ 94,416 Total debts 2022: € 94,416 First fiscal year in the series	€ 86,579 Total debts 2023: € 86,579 ▼ 8% vs 2022 (€ 94,416) Favourable step	€ 59,625 Total debts 2024: € 59,625 ▼ 31% vs 2023 (€ 86,579) Favourable step	€ 10,313 Total debts 2025: € 10,313 ▼ 83% vs 2024 (€ 59,625) Favourable step	▼ 83%
Cash	€ 66,835 Cash 2022: € 66,835 First fiscal year in the series	€ 90,256 Cash 2023: € 90,256 ▲ 35% vs 2022 (€ 66,835) Favourable step	€ 75,089 Cash 2024: € 75,089 ▼ 17% vs 2023 (€ 90,256) Unfavourable step	€ 12,740 Cash 2025: € 12,740 ▼ 83% vs 2024 (€ 75,089) Unfavourable step	▼ 83%
Land & buildings	€ 128,573 Land & buildings 2022: € 128,573 First fiscal year in the series	€ 125,835 Land & buildings 2023: € 125,835 ▼ 2% vs 2022 (€ 128,573) Unchanged	€ 123,097 Land & buildings 2024: € 123,097 ▼ 2% vs 2023 (€ 125,835) Unchanged	€ 120,358 Land & buildings 2025: € 120,358 ▼ 2% vs 2024 (€ 123,097) Unchanged	▼ 2%
Retained profit	€ 108,877 Retained profit 2022: € 108,877 First fiscal year in the series	€ 141,267 Retained profit 2023: € 141,267 ▲ 30% vs 2022 (€ 108,877) Favourable step	€ 149,728 Retained profit 2024: € 149,728 ▲ 6% vs 2023 (€ 141,267) Favourable step	€ 132,874 Retained profit 2025: € 132,874 ▼ 11% vs 2024 (€ 149,728) Unfavourable step	▼ 11%
Dividend	€ 3,695 Dividend 2022: € 3,695 First fiscal year in the series	€ 4,884 Dividend 2023: € 4,884 ▲ 32% vs 2022 (€ 3,695) Unchanged	€ 23,648 Dividend 2024: € 23,648 ▲ € 18,764 vs 2023 (€ 4,884) Unchanged	€ 53,050 Dividend 2025: € 53,050 ▲ 124% vs 2024 (€ 23,648) Unchanged	▲ 124%
Bank debt	€ 41,052 Bank debt 2022: € 41,052 First fiscal year in the series	€ 28,420 Bank debt 2023: € 28,420 ▼ 31% vs 2022 (€ 41,052) Favourable step	€ 15,789 Bank debt 2024: € 15,789 ▼ 44% vs 2023 (€ 28,420) Favourable step	€ 3,157 Bank debt 2025: € 3,157 ▼ 80% vs 2024 (€ 15,789) Favourable step	▼ 80%
Balance sheet total	€ 204,293 Balance sheet total 2022: € 204,293 First fiscal year in the series	€ 228,846 Balance sheet total 2023: € 228,846 ▲ 12% vs 2022 (€ 204,293) Unchanged	€ 210,353 Balance sheet total 2024: € 210,353 ▼ 8% vs 2023 (€ 228,846) Unchanged	€ 144,187 Balance sheet total 2025: € 144,187 ▼ 31% vs 2024 (€ 210,353) Unchanged	▼ 31%

Key figures of Dr. Marleen Vandepitte, huisarts, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to Dr. Marleen Vandepitte, huisarts?

What happened at Dr. Marleen Vandepitte, huisarts in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jul 20, 2026 New annual accounts for financial year 2025: profit of € 36,197 (▲ 13% vs 2024). Source: NBB ↗
2020 Marleen Vandepitte became a director. NBB
Jan 3, 2011 New establishment in Gent. KBO
Dec 16, 2010 Incorporation, published in the Gazette. Source: Staatsblad ↗

In short

From € 27,294 profit in 2022 to € 36,197 profit in 2025.

Paid € 70,667 in corporate taxes since 2022.

Best year ever: 2023, with € 37,275 profit.

Paid out € 85,278 in dividends to the owners in total.

Original PDFs at the National Bank ↗

Management

Marleen Vandepitte

Dr. Marleen Vandepitte, huisarts

Behind Dr. Marleen Vandepitte, huisarts is Marleen Vandepitte.

Directors

According to the 2025 annual accounts

Marleen Vandepitte

Director

since 2020

Establishments

Establishment units

Physical locations of this company

Registered office

Sint-Lievenspoortstraat 257 box 1

9000 Gent

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.

All companies at this address →

LUCID OAK

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Shareholders according to the Official Gazette deeds

Who contributed at incorporation and at capital increases, with the deed as source. Later share transfers are not published in the Gazette.

Incorporation

16 December 2010 Source: Deed ↗

Bart Wydaeghe(associé commandité) 90%
Marleen Vandepitte(associée commanditaire) 10%

Details

Company number: 0831.631.181
VAT number: BE 0831.631.181
Registered office: Sint-Lievenspoortstraat 257 bus 1, 9000 Gent
Names & denominations: Dr. Marleen Vandepitte, huisarts
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 6 December 2010
Peppol: Active · Active since 8 Feb 2025

View on CBE Public ↗ Annual accounts (NBB) ↗